This is HUGE news! SurVaxM, a therapeutic cancer vaccine designed to delay the progression of the deadliest form of brain cancer, Glioblastoma, nearly DOUBLED the survival time of patients in an EARLY clinical trial.
— Chise (@sailorrooscout) June 13, 2023
Let’s talk about that! 🧵⬇️